Association of Fucosyltransferase 2 Gene Variant with Inflammatory Bowel Diseases: A Meta-Analysis.


Journal

Medical science monitor : international medical journal of experimental and clinical research
ISSN: 1643-3750
Titre abrégé: Med Sci Monit
Pays: United States
ID NLM: 9609063

Informations de publication

Date de publication:
07 Jan 2019
Historique:
entrez: 8 1 2019
pubmed: 8 1 2019
medline: 23 3 2019
Statut: epublish

Résumé

BACKGROUND Ulcerative colitis (UC) and Crohn's disease (CD) are the 2 main type of inflammatory bowel diseases (IBDs). Several studies have been conducted to investigate the association of fucosyltransferase 2 gene (rs601338) variant with UC and CD, but the results were inconsistent. Here, we performed a meta-analysis to clarify this issue based on a relatively larger sample size. MATERIAL AND METHODS A systematic literature search was conducted in PubMed, Embase, CNKI, and Chinese Wangfang databases up to 31 May 2018. Meta results were synthesized by using crude odds ratio with 95% confidence interval. Heterogeneity, sensitivity analysis, subgroup analysis, and publication bias were assessed using STATA 11.0 software. RESULTS A total of 8 relevant studies including 3874 IBDs patients (1872 UC cases, 2002 CD cases) and 5445 controls were included for meta-analysis. We found a significant association between rs601338 A allele and risk of IBDs in the Chinese population (OR=2.35, 95%CI=1.66~3.34, P=0.001), but not in whites. Stratified by disease type, we found a significant association between rs601338 polymorphism with CD and UC in the Chinese population, but not in the white population. In addition, funnel plot and Egger's linear regression test suggests no publication bias in all genetic models. CONCLUSIONS Fucosyltransferase 2 gene (rs601338) polymorphism is associated with susceptibility to IBD, UC, and CD in the Chinese population, but these results might not be generalizable to other ethnic populations. Further well-designed studies are needed to confirm these findings.

Identifiants

pubmed: 30615603
pii: 911857
doi: 10.12659/MSM.911857
pmc: PMC6338007
doi:

Substances chimiques

Fucosyltransferases EC 2.4.1.-

Types de publication

Journal Article Meta-Analysis

Langues

eng

Sous-ensembles de citation

IM

Pagination

184-192

Références

Nature. 2001 May 31;411(6837):599-603
pubmed: 11385576
J Biol Chem. 2003 Apr 18;278(16):14112-20
pubmed: 12562767
Curr Opin Gastroenterol. 2006 Jul;22(4):361-4
pubmed: 16760750
Science. 2006 Dec 1;314(5804):1461-3
pubmed: 17068223
Nat Genet. 2007 Feb;39(2):207-11
pubmed: 17200669
Nat Genet. 2007 May;39(5):596-604
pubmed: 17435756
Nat Genet. 2008 Aug;40(8):955-62
pubmed: 18587394
Blood. 2010 Jun 10;115(23):4635-43
pubmed: 20308598
J Surg Oncol. 2010 Jun 15;101(8):706-12
pubmed: 20512947
Hum Mol Genet. 2010 Sep 1;19(17):3468-76
pubmed: 20570966
Gut. 2011 Oct;60(10):1354-62
pubmed: 21421666
Jpn J Infect Dis. 2011;64(2):95-103
pubmed: 21519121
J Gastroenterol. 2011 Sep;46(9):1056-63
pubmed: 21725903
Nat Rev Gastroenterol Hepatol. 2011 Dec 13;9(1):2
pubmed: 22158379
Nature. 2012 Apr 15;485(7397):256-9
pubmed: 22504179
World J Gastroenterol. 2012 Sep 14;18(34):4758-64
pubmed: 23002346
Gut Microbes. 2012 Nov-Dec;3(6):544-55
pubmed: 23060017
Tissue Antigens. 2012 Dec;80(6):488-93
pubmed: 23075394
Nature. 2012 Dec 6;492(7427):113-7
pubmed: 23160491
Gut. 2013 Jun;62(6):952-4
pubmed: 23297005
J Gastroenterol Hepatol. 2014 Oct;29(10):1778-85
pubmed: 24720527
Clin Rev Allergy Immunol. 2015 Jun;48(2-3):182-91
pubmed: 24828903
J Natl Cancer Inst. 1989 Jan 18;81(2):107-15
pubmed: 2642556
Immunol Invest. 2015;44(7):603-15
pubmed: 26436849
PLoS One. 2016 Jan 14;11(1):e0146557
pubmed: 26766790
Hum Immunol. 2016 Oct;77(10):990-996
pubmed: 27435931
Gastroenterol Res Pract. 2017;2017:4148651
pubmed: 28167958
Cancer Res. 1985 Sep;45(9):4499-511
pubmed: 4028031
BMJ. 1997 Sep 13;315(7109):629-34
pubmed: 9310563

Auteurs

Feng Zhou (F)

Department of Digestion, Zhejiang Hospital, Hangzhou, Zhejiang, China (mainland).

Qin Zhu (Q)

Department of Digestion, Zhejiang Hospital, Hangzhou, Zhejiang, China (mainland).

Pei-Fen Zheng (PF)

Department of Digestion, Zhejiang Hospital, Hangzhou, Zhejiang, China (mainland).

Yu-Liang Feng (YL)

Department of Digestion, Zhejiang Hospital, Hangzhou, Zhejiang, China (mainland).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH